Although a small percentage of patients (1%) with Alzheimer’s disease shows a mutation in one of the genes involved in the disease, including presenilins 1 and 2 or amyloid precursor protein (APP), most patients (around 90%) are called sporadic ones and depend on both genetic and environmental determinants [128]. Here, APP is linked to Alzheimer disease.